Equities

Bodycote PLC

Bodycote PLC

Actions
IndustrialsIndustrial Engineering
  • Price (GBX)612.00
  • Today's Change0.00 / 0.00%
  • Shares traded309.17k
  • 1 Year change+5.88%
  • Beta1.5855
Data delayed at least 20 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bodycote plc is a provider of heat treatment and thermal processing services. The Company's segments include Aerospace, Defense & Energy (ADE) and Automotive & General Industrial (AGI) business areas, which include ADE- Western Europe; ADE- North America; ADE-Emerging Markets; AGI-Western Europe; AGI-North America, and AGI-Emerging Markets. Its heat treatment processes include case hardening, tempering, solution and aging treatment, specialty stainless steel processes (S3P), annealing and normalizing. Its metal joining includes specialized processes such as electron beam welding, vacuum welding and honeycomb brazing. The Company’s surface technology products and services range from coating services, coating and application development, specialist coating sealing technologies, complete manufacture, and the supply of coating materials and technology transfer. The Hot Isostatic Pressing (HIP) services include Powdermet technologies, isostatic pressing services and HIP supporting services.

  • Revenue in GBP (TTM)781.40m
  • Net income in GBP62.60m
  • Incorporated1953
  • Employees4.83k
  • Location
    Bodycote PLCSpringwood Court, Springwood CloseMACCLESFIELD SK10 2XFUnited KingdomGBR
  • Phone+44 162 550 5300
  • Fax+44 162 550 5313
  • Websitehttp://www.bodycote.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Porvair plc180.10m15.43m304.78m1.01k19.552.0713.921.690.33560.33563.923.160.88433.536.14178,493.607.587.269.398.9636.0733.458.577.981.0811.900.164420.051.996.448.5411.501.555.46
Ceres Power Holdings plc39.51m-40.18m311.27m591.00--1.84--7.88-0.2083-0.20830.20480.87530.18252.145.2166,859.56-18.55---20.64--74.84---101.69--6.23--0.0152--12.82---13.43------
Essentra PLC309.70m600.00k427.53m3.00k716.351.5613.621.380.0021-0.00071.070.9570.57621.284.36103,233.300.11160.17150.14110.223674.0462.470.19370.33611.284.620.3416---6.39-20.96116.43-24.91-26.42-29.52
Goodwin plc191.26m16.90m510.65m1.23k30.294.1818.802.672.252.2525.4116.280.69922.393.65156,129.006.486.228.808.6740.7233.039.268.681.4410.010.374861.672.978.536.288.005.586.69
Judges Scientific PLC135.60m14.90m581.86m714.0040.016.6619.934.292.192.1919.9813.140.7318--5.10189,916.008.2010.1210.1414.75--65.7211.2111.151.09--0.414264.7320.2211.81-23.622.2643.9418.89
Morgan Advanced Materials PLC1.13bn69.20m733.08m8.69k10.731.966.010.64680.24010.24253.931.311.07--5.20130,365.807.435.8110.328.68--58.926.925.591.418.350.484256.860.23381.52-46.38-3.952.611.76
ME Group International PLC304.20m52.90m810.04m1.05k15.414.908.592.660.13950.13950.80210.4390.9655.5918.66288,884.1016.78--23.80--34.69--17.39--1.3064.140.2682--14.58--30.61------
Vesuvius PLC1.87bn104.00m1.04bn11.38k10.340.8795.530.55320.38440.38446.924.520.8124.293.93164,469.105.085.157.056.7928.0527.086.266.361.0718.430.281952.13-5.741.42-34.57-2.9717.583.04
Bodycote PLC781.40m62.60m1.13bn4.83k18.591.547.651.440.32930.32934.123.980.691923.014.79161,680.105.635.787.327.4114.4736.378.149.080.704313.230.172262.917.921.9516.15-3.67-0.43133.62
Renishaw plc691.30m96.89m2.27bn5.26k23.422.5117.983.291.331.339.5112.410.662.145.35131,526.109.259.7310.2411.0046.1849.7214.0214.234.21--0.020147.590.39623.79-16.550.99-1.034.90
Rotork PLC745.89m119.16m2.72bn3.30k23.074.5019.413.640.13820.13820.86520.70861.024.165.68226,028.2016.4712.7919.8315.4848.4246.4916.0914.572.45--0.019260.8412.050.664921.334.28-2.074.06
IMI plc2.21bn253.30m4.39bn10.90k17.674.3111.661.990.96980.96988.463.980.87722.564.10202,752.3010.059.2615.1813.5846.1645.3011.4610.030.823515.400.405935.587.172.864.866.976.47-6.96
Spirax Group PLC1.66bn191.90m4.79bn10.12k25.054.1516.342.892.602.6022.4615.690.6174--5.19163,880.707.169.428.8811.78--76.3411.5913.921.618.140.49750.674.477.85-18.29-3.8218.639.86
Data as of Nov 21 2024. Currency figures normalised to Bodycote PLC's reporting currency: UK Pound GBX

Institutional shareholders

50.66%Per cent of shares held by top holders
HolderShares% Held
Martin Currie Investment Management Ltd.as of 07 Mar 202313.24m7.17%
Goldman Sachs Advisors BVas of 06 Sep 202413.22m7.15%
Franklin Templeton Fund Management Ltd.as of 01 Nov 202411.90m6.44%
Artemis Investment Management LLPas of 22 Oct 202410.93m5.92%
Fidelity Management & Research Co. LLCas of 02 Aug 20239.75m5.28%
Baillie Gifford & Co.as of 07 Mar 20239.19m4.97%
Newton Investment Management Ltd.as of 07 Mar 20237.43m4.02%
Alantra EQMC Asset Management SGIIC SAas of 07 Mar 20236.51m3.52%
The Vanguard Group, Inc.as of 07 Mar 20236.24m3.38%
Royal London Asset Management Ltd.as of 01 Nov 20245.20m2.81%
More ▼
Data from 30 Sep 2023 - 08 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.